期刊文献+

卡维地洛治疗心力衰竭作用机制的研究进展 被引量:15

下载PDF
导出
作者 王莉
出处 《中西医结合心脑血管病杂志》 2010年第2期224-227,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献33

  • 1Colucei WS, Braunwald E. Pathophysiology of heart failure in braunwold E (eds) heart disease [C]. 5thed. Philadel Phia: WB Saunders Company, 1997 : 360.
  • 2夏合中,李鼎,张彦周,龚辉,闫西艴,张玉芳.卡维地洛对降压及血清Ⅲ型前胶原氨基端肽的影响[J].临床心血管病杂志,2001,17(11):518-519. 被引量:4
  • 3Grimm D, Michaela H,Jabusch HC,et al. Extracelluar matrix proteins in cardiac fibroblasts derived from rat heart with chronic pressure overload: Effeels of hetar receptor blockadel[J].J Mol Cell Cardiol, 2001,33:487.
  • 4吴强,李隆贵,耿昭华.心肌梗死后心衰大鼠心肌细胞凋亡和凋亡相关基因表达的变化[J].第三军医大学学报,2002,24(4):434-436. 被引量:14
  • 5Gruseppe M, Guido G, Cristina G, et al. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage [J]. Hypertension, 1999,34 (4) : 724.
  • 6吴小盈,宋建平,李红霞,蒋文平.培哚普利和卡维地洛对自发性高血压大鼠Ang Ⅱ和B型利钠肽的影响[J].高血压杂志,2004,12(1):80-82. 被引量:17
  • 7San F,Sawyer DB,Cheng DL,et al. Progressive left ventricular remodeling and apoptosis late after mycocardial infarction in mouse heart[J]. Am J Phys ol Cric Phys ol,2000,279(2):422.
  • 8Spallarossa P, Garibaldi S, Altieri P, et al. Carvedilol prevents doxorubicin- induced free radical release and apoptosis in cardiomyoeytes in vitro[J]. J Mol Cell Cardiol,2004,37(4) :837.
  • 9Yue TL, Ma XI, Wang XK,et al. Possible involvement of stress activated protein kinase signaling pathway and Fas receptor ex pression in prevention of ischemia/reperfusion induced cardiomyocyte apoptosis by carvedilol[J]. Cric Res, 1998,82(2) : 166.
  • 10Rossing L, Hacbdeler J, Mallat Z, et al. Congestive heart failure induces endothelial cell apoptosis: Protective role of carvedilol [J].J Am Coll Cardiol,2001,36(7) :2081.

二级参考文献61

  • 1胡咏梅,李法琦.氧化应激对心衰大鼠ET-1的影响及β-阻滞剂的干预[J].岭南心血管病杂志,2003,9(2):130-133. 被引量:7
  • 2邓春玉,林曙光,杨敏,钱卫民,张燕,吴书林.卡维地洛对大鼠心室肌细胞钠通道的影响[J].中国药理学通报,2005,21(5):568-572. 被引量:7
  • 3杨广,李小鹰.卡维地洛、美托洛尔对心衰大鼠心功能及体液因子的影响[J].山东医药,2006,46(13):4-6. 被引量:8
  • 4[1]Gruseppe M, Guido G, Cristina G,et al. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension, 1999,34:724-728.
  • 5[2]Diez J, Laviades C, Mayor G, et al. Increased serum concentration of procollagen peptides in essential hypertension relation to cardiac alteration. Circulation, 1995,91:1450-1456.
  • 6[3]Pierre-Emmanuel M, Julier D, Jan K, et al. Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic bonding. Hypertension, 1999,34:1197-1201.
  • 7[4]Marvin M, Wiliam F. Results of therapy with carvedilol, αβ-blocker vasodilator with antioxidant properties in hypertension patients. Am J Hypertens,1998,11:155-225.
  • 8[1]Yanagisawa M. A novel potent vasoconstrictor produced by vascular endothelial cell. Nature, 1988, 332:411
  • 9[2]Barton M, Kiowski W. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease. Curr Hypertens Rep, 2001, 3:322~330
  • 10[3]Kinugawa S, Tsutsui H, Hayashidani S, et al. Treatment with dimethylthiourea prevents left ventricular remodeling and fai-lure after experimental myocardial infarction in mice:role of oxdative stress. Circ Res, 2000, 87:392~398

共引文献59

同被引文献89

引证文献15

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部